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ABSTRACT	  
A	   comparative,	   cross-­‐sectional	   study	   was	   designed	   to	   assess	   the	   adherence	   of	  
prescribers	  with	  national	  standard	  treatment	  guidelines	  for	  malaria	  in	  all	  the	  twenty	  
public	  and	  private	  tertiary	  healthcare	  facilities	  in	  the	  two	  cities	  of	  Pakistan.	  A	  total	  
of	   600	   patient	   encounters	   were	   assessed	   with	   the	   national	   standard	   treatment	  
regimen	   for	  malaria.	   No	   significant	   difference	   at	   (p	   ≤	   0.05)	   was	   observed	   among	  
adherence	  of	  prescribers	  having	  different	  designations	  and	  levels	  of	  experience	  with	  
standard	  treatment	  regimen	  for	  malaria	  in	  the	  two	  cities.	  The	  results	  of	  the	  present	  
study	   showed	   low	   adherence	   of	   prescribers	  with	   standard	   treatment	   regimen	   for	  
malaria	  in	  Pakistan.	  
Palabras	  clave:	  Adherence;	  Malaria;	  Pakistan;	  Standard	  treatment	  guidelines.	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RESUMEN	  
Juicio	   sobre	   la	  adherencia	  a	   las	  directrices	  de	   tratamiento	  de	   la	  malaria.	  Un	  
estudio	  transversal	  comparativo	  en	  Pakistán	  
Se	   diseñó	   un	   estudio	   transversal	   comparativo	   para	   evaluar	   la	   adherencia	   de	   los	  	  
prescriptores	   a	   las	   pautas	   estándar	   nacionales	   de	   tratamiento	   de	   la	   malaria,	   en	  
veinte	   instalaciones	   sanitarias	   terciarias,	   	   públicas	   y	   privadas,	   de	   dos	   ciudades	   de	  
Pakistán.	  Se	  evaluaron	  un	  total	  de	  600	  encuestas	  a	  pacientes	  sometidos	  al	  régimen	  
estándar	   nacional	   de	   tratamiento	   contra	   la	   malaria.	   No	   se	   observó	   diferencia	  
significativa	  alguna	   (a	  nivel	  de	  p	  ≤	  0.05)	   	   sobre	   la	  adherencia	  de	  prescriptores	  con	  
diferentes	   niveles	   de	   experiencia	   con	   el	   régimen	   de	   tratamiento	   estándar	   para	   la	  
malaria	   en	   las	   dos	   ciudades.	   Los	   resultados	   del	   presente	   estudio	   mostraron	   baja	  
adhesión	  de	  los	  prescriptores	  al	  régimen	  de	  tratamiento	  estándar	  para	  la	  malaria	  en	  
Pakistán.	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1.	  INTRODUCTION	  The	   rational	   use	   of	   drugs	   demands	   that	   appropriate	   drugs	   must	   be	  prescribed	  and	  available	  at	  the	  right	  time	  and	  at	  an	  affordable	  price	  to	  the	  patients.	  Prescribing	  patterns	  might	  influence	  the	  effectiveness	  of	  treatment	  and	  the	  control	  of	  disease.	  Inadequate,	  excessive	  or	  incorrect	  prescribing	  practices	  are	  most	  likely	  to	   be	   the	   commonest	   forms	   of	   irrational	   prescribing	   habits.	   Development	   of	  resistance	   to	   antibiotics,	   ineffective	   treatment,	   adverse	   effects,	   drug	   dependence	  and	   economic	   burden	   to	   the	   patient	   and	   society	   due	   to	   irrational	   prescribing	  practices	  are	  the	  major	  dilemma	  of	  present	  medical	  practice	  in	  case	  of	  malaria	  (1).	  Rational	   prescribing	   requires	   that	   the	   prescribers	   adhere	   to	   standard	  treatment	   guidelines	   to	   facilitate	   a	   constant,	   therapeutically	   effective	   and	  economically	   efficient	   use	   of	   drugs.	   This	   greatly	   enhance	   the	   compliance	   of	  patients	   and	   outcome	   of	   therapy	   (2).	   But	   most	   of	   the	   medical	   practitioners	   in	  developing	  countries	  including	  Pakistan	  are	  prone	  to	  practice	  their	  own	  protocols	  to	  treat	  malaria	  rather	  than	  adhering	  to	  standard	  regimens.	  Promoting	  the	  rational	  use	  of	  drugs	  remains	  a	  major	  challenge.	  	  Standard	   treatment	   guidelines	   are	   one	   of	   the	   tools	   to	   support	   effective	  clinical	  practice	  and	  promotion	  of	  rational	  use	  of	  drugs.	  These	  guidelines	  must	  be	  implemented	   and	   the	   monitoring	   of	   case	   management	   according	   to	   these	  guidelines	  must	  be	  evaluated	  (3).	  Standard	  treatment	  guidelines	  for	  Malaria	  have	  been	   formulated	   and	   introduced	   in	   2005	   through	   collaborative	   efforts	   of	  directorate	   of	   malaria	   control,	   WHO	   and	   technical	   core	   group	   in	   Pakistan	   (4).	  Chloroquine	   is	   recommended	   as	   first	   line	   drug	   in	   the	   treatment	   of	   all	   types	   of	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malaria.	   Sulfadoxine/pyrimethamine	   and	   artemether/lumefentrine	   are	  recommended	   as	   first	   line	   drugs	   for	   treatment	   of	   confirmed	   cases	   of	  Plasmodium.falciparum.	  Chloroquine	  along	  with	  premaquine	  combination	  is	  used	  as	  anti	  relapse	  therapeutic	  agents	  in	  case	  of	  Plasmodium.vivax	  (4)	  (Table	  1).	  	  
Table	  1.-­‐	  Standard	  treatment	  guidelines	  for	  malaria	  in	  Pakistan.	  
Anti-malarial drugs Dosage 
form 
Comments 
Chloroquine is first choice of drug in all cases of malaria when type not confirmed 
through laboratory test for empiriacl therapy 
                               Standard treatment regimen for P.vivax 
Chloroquine + 
primaquine 
Tablets Chloroquine 25mg/kg for 3days + primaquine 
0.25mg/kg O.D for 14 days. 
Primaquine  Tablets 0.75mg/kg body weight once a week for 8weeks. 
                            Standard treatment regimen for confirmed cases of P.falciparum 
Artemether 
+lumefantrine 
Tablets Artemether 20mg +lumefantrine 120mg two 
doses per day for 3 days. 
Artesunate 
+tetracycline 
Tablets Artesunate 20mg /kg O.D +tetracycline 4mg/kg 
Q.I.D for 7days. 
Dihydroartemisinin+ 
piperaquine 
Tablets Dihydroartemisinin 4mg/kg/day +piperaquine 
18mg/kg/day for 3days. 
Single dose 
piperaquine  
Tablets (0.75 mg/kg) to ACT treatment 
*Directorate	  of	  Malaria	  Control	  and	  WHO,	  National	  treatment	  guidelines	  for	  malaria.	  2005	  	   Although,	   standard	   treatment	   guidelines	   are	   available	   in	   the	   country,	   still	  prescribing	  and	  dispensing	  practices	  are	  not	  up	  to	  the	  desired	  standards	  in	  public	  and	  private	  healthcare	  facilities	  in	  Pakistan	  (5).	  	  There	   is	   lack	   of	   research	   on	   evaluating	   the	   adherence	   of	   prescribing	  practices	   with	   these	   standard	   treatment	   guidelines,	   which	   in	   turn	   has	   strong	  influence	  on	  malaria	  treatment	  practices	  (6).	  Therefore,	  the	  main	  objective	  of	  the	  present	  study	  was	   to	  assess	   the	  adherence	  of	  prescribers	  with	  national	   standard	  treatment	  guidelines	  for	  malaria	  in	  the	  two	  cities	  of	  Pakistan;	  Islamabad	  (national	  capital)	  and	  in	  its	  twin	  city	  Rawalpindi.	  	  The	   study	   will	   provide	   baseline	   data	   regarding	   adherence	   of	   prescribers	  with	  standard	  treatment	  guidelines,	  which	  can	  serve	  as	  a	  basis	  for	  potential	  areas	  for	   intervention	   to	   implement	   the	   standard	   treatment	   guidelines	   effectively	   to	  improve	  rational	  drug	  use	  in	  the	  healthcare	  system.	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2.	  MATERIALS	  AND	  METHODS	  
Study	  design	  A	   comparative,	   cross-­‐sectional	   study	   was	   designed	   to	   evaluate	   the	   case	  records	   of	   patients	   from	  October	   2010-­‐	   2011	   including	   (daily	   registers,	  medical	  records,	   prescriptions,	   patient-­‐held	   records)	   treated	   for	   malaria	   in	   public	   and	  private	   tertiary	  healthcare	   facilities	   in	   the	   twin	   cities,	  namely	   Islamabad	   (federal	  capital)	  and	  Rawalpindi.	  	  
Study	  tool	  The	  case	  records	  were	  collected	  from	  the	  male	  and	  female	  medicine	  wards	  and	  out-­‐patient	  departments	  (OPD)	  of	  the	  healthcare	  facilities.	  A	  pre-­‐validated	  tool	  i.e.	   WHO	   prescribing	   indicator	   form	   was	   used	   to	   collect	   data	   regarding	   current	  prescribing	  practices	  for	  the	  treatment	  of	  malaria(7).	  	  The	  prescribing	  form	  included	  five	  core	  indicators	  such	  as	  %	  of	  encounters	  having	  diagnosis,	   average	  number	  of	  drugs	  per	  encounter,	  %	  average	  number	  of	  antibiotics	  and	  injections	  prescribed	  per	  encounter	  and	  %	  of	  drugs	  prescribed	  by	  generic	  names.	  Beside	  this	  few	  additional	  indices	  such	  as	  demographics	  of	  patient,	  type	   of	   drug	   combinations	   prescribed	   and	   availability	   of	   standard	   treatment	  guidelines	  in	  the	  healthcare	  facilities	  were	  also	  assessed.	  	  Prescriptions	   were	   also	   assessed	   for	   the	   prescribed	   anti-­‐malarial	   drugs,	  their	  doses,	   strengths,	   frequencies	  and	  durations	  of	  use	   to	   check	  whether	   if	   they	  followed	  national	  standard	  treatment	  regimen	  or	  not.	  The	  minimum	  requirement	  for	   the	   adherence	   of	   prescriptions	   with	   standard	   treatment	   regimen	   was	  elaborated	  and	  transformed	  into	  measurable	  adherence	  indicators	  scale.	  The	  scale	  included	   five	   indicators	   including	   correct	   prescribing	   of	   right	   anti-­‐malarial	   drug,	  its	  dose,	  strength,	  frequency	  and	  duration	  of	  use.	  The	  composite	  score	  for	  the	  scale	  was	   5-­‐10	   and	   lower	   score	   referred	   to	   better	   adherence	   with	   the	   standard	  treatment	  regimen.	  Data	  collection	  was	  planned	  and	  permission	  for	  survey	  was	  obtained	  from	  relevant	   district	   health	   officers	   (DHO)	   and	   Medical	   superintendents	   (MS)	   of	  respective	   healthcare	   facilities.	   The	   study	  was	   also	   approved	   by	  Malaria	   Control	  Program,	  Ministry	  of	  Health,	  Government	  of	  Pakistan.	  	  
Sampling	  of	  facilities	  and	  patient	  encounters	  Keeping	   in	  view	  the	  federal	  administrative	  and	  regulatory	  structure	  of	   the	  country	   and	   due	   to	   location	   and	   operation	   of	   Malaria	   Control	   Program	   in	   the	  capital	   city,	   two	  main	   cities	   of	   Pakistan	   namely	   Islamabad	   and	  Rawalpindi	  were	  selected	   for	   the	   study.	   The	   public	   healthcare	   facilities	   providing	   services	   at	  provincial	  and	  district	  levels	  are	  categorized	  as:	  primary	  level	  health	  care	  facilities	  (basic	  health	  units,	  rural	  health	  centers,	  mother	  &	  child	  health	  centers,	  TB	  clinics	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and	   dispensaries),	   secondary	   level	   health	   care	   facilities	   (tehsil	   headquarter	  hospitals	   and	   district	   head	   quarter	   hospitals)	   and	   tertiary	   level	   health	   care	  facilities	   (tertiary	  hospitals,	  post	   graduate	  medical	   institutes,	   teaching	  hospitals).	  All	   the	   tertiary	   healthcare	   facilities	   have	   a	   primary	   section	   for	   treating	   common	  disease	  including	  malaria.	  	  Cases	   are	   referred	   from	   lower	   to	   higher	   level	   depending	   on	   severity	   of	  problem	   and	   available	   infrastructure	   (8).	   The	   study	   population	   included	   all	   the	  public	  and	  private	  tertiary	  health	  care	  facilities	  treating	  malaria	  in	  Islamabad	  and	  Rawalpindi.	   A	   list	   of	   all	   the	   public	   and	   private	   tertiary	   healthcare	   facilities	   was	  obtained	   from	   respective	   District	   Health	   Offices.	   All	   the	   20	   public	   and	   private	  tertiary	  healthcare	   facilities	  were	  selected	   for	   the	  study	  and	   the	  sample	  size	  was	  Islamabad	  (n	  =10,	  5	  each	  public	  and	  private	  healthcare	  facilities)	  and	  Rawalpindi	  (n	  =10,	  5	  each	  public	  and	  private	  healthcare	  facilities).	  	  For	   assessing	   the	   prescribing	   practices	   in	   each	   facility,	   thirty	   patients	  treated	  for	  malaria	  by	  the	  prescribers	  over	  the	  last	  one	  year	  were	  reviewed	  (7).	  	  A	   total	   of	   600	   patient	   encounters	   i.e.	   300	   from	   each	   sector	   (public	   and	  private)	  healthcare	  facilities	  situated	  in	  both	  cities	  were	  collected	  randomly	  from	  daily	   registers,	  medical	   records,	   prescriptions,	   patient-­‐held	   records.	   At	   least	   two	  patients	  encounter	  per	  month	  during	  the	  low	  season	  (October	  till	  April)	  and	  four	  patients	   encounter	   per	   month	   during	   the	   high	   season	   (May	   till	   September)	   for	  malaria	  were	  selected.	  	  As	  there	  is	  no	  trend	  of	  laboratory	  confirmation	  of	  malaria	  in	  Pakistan	  all	  the	  prescriptions	  with	   diagnosis	   of	  malaria,	   anti-­‐malarial	   drugs	   and	   tests	   of	  malaria	  parasite	   results	   were	   included	   in	   the	   sample.	   Plasmodium	   vivax	   is	   common	   in	  Rawalpindi	   and	   Islamabad	   so	   the	   adherence	   of	   prescribers	   with	   standard	  treatment	  regimen	  for	  P.vivax	  was	  assessed.	  	  Interview	   of	   the	   head	   of	   the	   outpatient	   department	   on	   recommended	  current	  prescribing	  practices	  in	  the	  healthcare	  facilities	  were	  recorded	  and	  applied	  to	  all	  encounters	  where	  records	  were	  missing	  (9).	  Prescriptions	  without	  the	  name	  of	   the	   prescriber	   and	   folder	   without	   patient’s	   information	   were	   excluded.	   The	  prescribers	  were	  identified	  from	  patient’s	  prescriptions	  and	  information	  regarding	  their	  designation	  and	  experience	  was	  recorded.	  
Data	  collection	  and	  analysis	  	  	   Data	   was	   collected	   by	   the	   principal	   investigator	   along	   with	   two	   teams	  comprised	   of	   five	   trained	   data	   collectors	   in	   each	   team	   trained	   by	   the	   group	   of	  experts	  including	  principal	  investigator	  (9).	  	  The	   data	   collectors	   were	   trained	   students	   of	   the	   final	   year	   Doctor	   of	  Pharmacy	  program	  who	  tallied	  data	  with	  standard	  treatment	  regimen.	  Data	  were	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coded	   and	   analyzed	   using	   statistical	   software	   SPSS	   version	   16.	   Descriptive	  statistics	   (frequencies	   and	   percentages)	   were	   used	   to	   describe	   trends	   in	   the	  current	  prescribing	  practices.	  Kruskal-­‐Wallis	  test	  (p	  ≤	  0.05)	  was	  used	  to	  compare	  the	   adherence	   of	   prescribers	   with	   standard	   malaria	   regimen	   having	   different	  designations	   and	   level	   of	   experiences.	  While	  Mann	  Whitney	   test	   (p	   ≤	   0.05)	  was	  used	   to	   compare	   the	   adherence	   of	   prescribers	  with	   standard	   treatment	   regimen	  for	  malaria	  practicing	  in	  public	  and	  private	  healthcare	  facilities	  in	  the	  two	  cities.	  
3.	  RESULTS	  A	   total	   of	   600	   malaria	   cases	   were	   collected	   and	   analyzed.	   Out	   of	   600	  encounters,	   50	  %	   (n=300)	   were	   collected	   from	   public	   and	   50	  %	   (n=300)	   were	  from	  private	  tertiary	  healthcare	  facilities.	  	  The	  mean	   age	   of	   the	  malaria	   patients	   in	   the	   encounters	  was	   35.00	   years	  (±	  14.04),	  ranging	  from	  20	  to	  60	  years	  while	  68.3%	  (n=410)	  of	  the	  patients	  were	  males	  and	  remaining	  31.7%	  (n=190)	  were	  females.	  	  Of	   the	   total	   prescriptions,	   34.3	   %	   (n=	   206)	   were	   prescribed	   by	   house	  officers	  (fresh	  MBBS	  graduate	  acquiring	  training	  in	  medical	  fertinity),	  57.7	  %	  (n	  =	  346)	  were	  by	  medical	  officers	  (Medical	  graduate	  with	  at	  least	  experience	  of	  more	  than	  one	  year)	  and	  remaining	  8	  %	  (n	  =	  48)	  were	  by	  specialists	  (Medical	  graduate	  with	  expertise	  in	  a	  specific	  field	  of	  medical	  fertinity).	  	  It	   was	   observed	   that	   20.2	   %	   (n	   =	   121)	   of	   the	   prescribers	   had	   working	  experience	  of	  less	  than	  one	  year,	  40.7	  %	  (n	  =	  244)	  had	  working	  experience	  of	  1-­‐5	  years,	  23.7	  %	  (n	  =	  142)	  had	  working	  experience	  of	  6-­‐10	  years	  and	  15.5	  %	  (n	  =	  93)	  had	  working	  experience	  of	  more	  than	  10	  years.	  Of	  the	  total	  prescribers,	  85	  %	  (n=	  510)	  were	  not	  aware	  regarding	  national	  standard	  treatment	  guidelines	  for	  malaria,	  90	  %	  (n	  =	  540)	  have	  never	   seen	   them	   in	   their	  health	   facilities	   for	   reference	  and	  98.3	  %	  (n	  =	  590)	  had	  never	  received	  any	  training	  on	  standard	  treatment	  guidelines	  for	  malaria	  (Table	  2).	  	  The	  mean	  number	  of	  drugs	  per	  encounter	  was	  2.37	  (±	  0.557),	  ranging	  from	  1	   to	  5	  drugs	  per	   encounter	  while	  mean	  number	  of	   antibiotics	   and	   injections	  per	  encounter	  were	  0.32	  (±	  0.513)	  and	  0.23	  (±	  0.470),	  ranging	  from	  1	  to	  2	  antibiotics	  and	   injections	   per	   encounter	   respectively.	   Diagnosis	  was	  written	   on	   37.2%	   (n	   =	  226),	   of	   the	   prescriptions	   while	   results	   of	   Malarial	   Parasite	   (MP)	   test	   was	  mentioned	   in	   only	   9.2	   %	   (n=	   55)	   of	   the	   cases.	   In	   29.1%	   (n=	   175)	   of	   the	   cases	  antibiotics	  and	  in	  21.6%	  (n=	  126)	  of	  the	  cases	  injections	  were	  prescribed.	  	  Drugs	  were	   prescribed	   by	   their	   generic	   names	   in	   only	   3%	   (n=	   18)	   of	   the	  cases.	  While	  dose	  of	  the	  anti-­‐malarial	  drugs	  was	  not	  calculated	  as	  per	  patient	  body	  weight	   in	   any	   of	   the	   encounters.	   The	   most	   commonly	   prescribed	   anti-­‐malarial	  drugs	  were	  chloroquine	  phosphate	  11	  %	  (n=	  66),	  artemether/lumefantrine	  17.4	  %	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(n=	  321),	   artemether	  17.4	  %	  (n=	  104),	   sulphadoxine/pyremethamine	  10.5%	  (n=	  63)	  and	  amidaquine	  HCl	  7.7	  %	  (n=	  46)	  (Table	  3).	  
Table	  2.-­‐	  Demographics.	  
	  
Table	  3.-­‐	  Prescribing	  trends	  in	  tertiary	  healthcare	  facilities.	  
	  	   	  










Less than one year 
1-5 years 
6-10 years 






Prescribers aware of malaria STGs  
Yes 
No 
                     
  90 (15) 
510 (85) 
 




  60 (10) 
540 (90) 
 




  10 (1.7) 
590 (98.3) 
Indicator Prescriptions                               
n = 600                                  
F (%) 
Diagnosis written on prescriptions 226 (37.7 %) 
Results of MP test on prescriptions 55 (9.2 %) 
Antibiotics prescribed 175 (29.2 %) 
Injections  prescribed 126 (21 %) 
Anti-pyretic  prescribed 554 (92.4 %) 
Prescribing by generic name 18 (3 %) 
Chloroquine phosphate  prescribed 66 (11 %) 
Artemether/lumefentraine  prescribed 321 (53.5 %) 
Artemether  prescribed 104 (17.3 %) 
Sulphadoxine/pyremethamine  prescribed 63 (10.5 %) 
Amodiaquine HCl  prescribed 46 (7.7 %) 
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Out	  of	  600	  encounters,	  correct	  anti-­‐malarial	  drugs	  were	  prescribed	  in	  11	  %	  (n=	  66)	  of	  the	  cases,	  correct	  dose	  of	  anti-­‐malarial	  drugs	  used	  were	  given	  in	  10.1	  %	  (n=	   61)	   of	   the	   cases	   while	   correct	   strength	   of	   anti-­‐malarial	   drugs	   used	   was	  prescribed	   in	  9	  %	  (n=	  54),	   correct	   frequency	  of	   the	  drugs	  used	   in	  9.2	  %	  (n=	  55)	  and	  correct	  duration	  of	  drugs	  used	  in	  9	  %	  (n=	  54)	  of	  the	  cases	  respectively.	  	  A	  detail	  description	  of	  prescriptions	  prescribed	  according	   to	  malaria	  STGs	  in	  public	  and	  private	  healthcare	  facilities	  in	  the	  two	  cities	  is	  given	  in	  (Table	  4).	  	  
Table	  4.-­‐	  Adherence	  of	  prescriptions	  with	  standard	  treatment	  guidelines	  for	  malaria	  in	  public	  and	  private	  tertiary	  healthcare	  facilities	  in	  the	  two	  cities.	  
	   No	   significant	   difference	   (p	   ≤	   0.05)	   was	   observed	   among	   adherence	   of	  prescriptions	  with	   standard	   treatment	   regimen	   for	  malaria	   in	  public	   and	  private	  healthcare	  facilities	  in	  the	  two	  cities	  (Table	  5).	  No	   significant	   difference	   (p	   ≤	   0.05)	   was	   observed	   among	   adherence	   of	  prescribers	  having	  different	  designations	   and	   levels	   of	   experience	  with	   standard	  treatment	  regimen	  for	  malaria	  (Table	  6).	  	   	  
Indicator Islamabad (n = 300) 
Prescriptions 
Rawalpindi (n = 300) 
Prescriptions 
Public                   
n= 150                    
F (%) 
Private        
n= 150           
F (%) 
Public           
n= 150            
F (%) 
Private            
n= 150              
F (%) 
Correct anti-malarial drug 
prescribed 
  13 (8.6 %) 23 (15.3 %) 19 (12.6 %) 11 (7.3 %) 
Correct dose of anti-malarial 
drugs prescribed 
 11 (7.3 %) 20 (13.3 %) 19 (12.6 %) 11 (7.3 %) 
Correct strength of anti-
malarial drugs prescribed 
 5 (3.3 %) 19 (12.6 %) 19 (12.6 %) 11 (7.3 %) 
Correct frequency of anti-
malarial drugs prescribed  
 8 (5.3%) 17 (11.3 %) 19 (12.6 %) 11 (7.3 %) 
Correct duration of anti-
malarial drugs prescribed 
 7 (4.6%) 17 (11.3 %) 19 (12.6 %) 11 (7.3 %) 
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Table	  5.-­‐	  Comparison	  of	  adherence	  of	  prescriptions	  with	  standard	  treatment	  guidelines	  for	  malaria	  prescribed	  in	  public	  and	  private	  tertiary	  healthcare	  facilities	  in	  the	  two	  cities.	  
Variables Adherence of prescriptions with standard treatment guidelines 
for malaria 
n Median U P value 
Cities Islamabad = 300 
Rawalpindi = 300 







Sector Public = 300 
Private = 300 
Public = 10 






Table	  6.-­‐	  Comparison	  of	  adherence	  of	  prescribers	  with	  standard	  treatment	  guidelines	  for	  malaria	  having	  different	  level	  of	  experience	  and	  designations	  working	  in	  tertiary	  healthcare	  facilities.	  
Variables Adherence of prescribers with standard treatment guidelines for 
malaria  
n Median H P value 
 
Experience 
Less than 1 year = 
121 
1-5 years = 244 
6-10 years = 142 
More than 10 years 
= 93 
Less than 1 year = 
10 
1-5 years = 10 
6-10 years = 10 
More than 10 years 








House officer = 206 
Medical officer = 
346 
Specialist = 48 
House officer = 10 
Medical officer = 
10 





4.	  DISCUSSION	  Irrational	  use	  of	  drugs	  is	  a	  major	  challenge	  faced	  by	  the	  healthcare	  systems	  of	   developing	   countries.	   Prescribing	   of	   anti-­‐malarial	   drugs	   to	   patients	   without	  evidence	   of	   malaria	   parasitaemia	   and	   the	   recurrent	   absence	   of	   treatment	   for	  alternative	  causes	  of	  disease	  is	  a	  common	  practice	  at	  healthcare	  facilities	  in	  these	  countries	  (10).	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Laboratory	  diagnosis	  can	  improve	  the	  treatment	  of	  malaria,	  but	  the	  results	  of	   the	  present	  study	  showed	  that	  only	   few	  facilities	  were	  offering	  any	   laboratory	  diagnostic	  services	  for	  the	  confirmation	  of	  malaria	  before	  prescribing	  anti-­‐malarial	  drugs	   to	   the	  patients.	  However,	   it	  was	  observed	   that	  prescribing	  of	   anti-­‐malarial	  drugs	  after	  laboratory	  confirmation	  only	  decreased	  significantly	  the	  total	  number	  of	  prescriptions	  in	  Malawi	  (11).	  	  Antibiotics	  are	  usually	  not	  preferred	  in	  the	  treatment	  of	  malaria	  and	  do	  not	  conform	  to	  the	  treatment	  guidelines.	  But	  prescribing	  of	  anti-­‐malarial	  drugs	  along	  with	  an	  antibiotic	  and	  an	  antipyretic	  was	  seen	  as	  a	  common	  practice	  at	  both	  public	  and	  private	  healthcare	  facilities.	  	  The	   results	   of	   the	   present	   study	   are	   in	   line	  with	   another	   study	   indicating	  overuse	  of	  antibiotics	  and	  injections	  promoting	  irrational	  drug	  use	  and	  higher	  rate	  of	   emergence	   of	   resistance	   of	   anti-­‐malarial	   drugs	   (12).	   Dose	   of	   the	   anti-­‐malarial	  drugs	  was	  not	  calculated	  as	  per	  patient	  body	  weight	  and	  drugs	  were	  mostly	  being	  prescribed	   by	   their	   brand	   names.	   The	   overall	   low	   generic	   prescribing	   observed	  was	  comparable	  to	  the	  results	  of	  the	  other	  studies	  conducted	  in	  Nigeria	  and	  Nepal	  (13,	  14).	  	  Chloroquine	   is	   usually	   the	   most	   commonly	   prescribed	   oral	   antimalarial	  drug	  in	  most	  of	  the	  countries	  as	  compared	  to	  quinine	  and	  other	  anti-­‐malarial	  drugs	  due	   to	   its	   continuous	   availability,	   affordable	   price	   or	   an	   established	   pattern	   by	  which	  most	   doctors	   treat	   uncomplicated	  malaria	   initially	   by	   giving	   chloroquine,	  followed	  by	  oral	  quinine	  for	  non-­‐responding	  cases.	  Similar	  pattern	  was	  followed	  in	  healthcare	  facilities	  in	  Nigeria	  (15).	  Although,	  Chloroquine	  is	  recommended	  as	  first	  line	  drug	  in	  the	  treatment	  of	  all	  types	  of	  malaria	  while	  Sulfadoxine/pyrimethamine	  and	   artemether/lumefentraine	   are	   only	   recommended	   as	   first	   line	   drugs	   for	  confirmed	   cases	   of	   Plasmodium	   falciparum	   in	   national	   standard	   treatment	  guidelines	  of	  Pakistan.	  	  The	  prevalence	  of	  P.	  vivax	  is	  more	  common	  in	  Punjab	  while	  P.	  falciparum	  is	  more	  frequently	  seen	  in	  Baluchistan	  and	  Sindh	  (4).	  But	  the	  results	  of	  the	  present	  study	   showed	   significant	   use	   of	   artemisinin	   based	   combination	   therapy	   for	   the	  treatment	  of	  malaria	  in	  Punjab	  although	  most	  of	  them	  were	  aware	  of	  the	  fact	  that	  
P.	  vivax	  is	  more	  common	  in	  Punjab.	  	  Rational	  prescribing	  requires	  that	  prescribers	  follow	  a	  standard	  process	  of	  prescribing	   and	   in	   accordance	   with	   standard	   treatment	   guidelines.	   High	   rate	   of	  inappropriate	  prescriptions	  for	  treating	  malaria	  are	  mostly	  due	  to	  lack	  or	  incorrect	  doses,	  frequency,	  dosages	  and	  duration	  of	  treatment	  (15).	  	  The	  result	  of	  the	  present	  study	  showed	  poor	  adherence	  of	  prescribers	  with	  the	   standard	   treatment	   guidelines	   for	   malaria.	   Prescribers	   having	   different	  designations	  and	  levels	  of	  experience	  working	  in	  public	  or	  private	  sector	  were	  not	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adhering	  to	  standard	  treatment	  guidelines.	  Most	  of	  the	  prescribers	  were	  unaware	  of	   the	   standard	   treatment	   guidelines	   and	   have	   never	   received	   any	   training	   on	  them.	  	  The	   standard	   treatment	   guidelines	   were	   not	   available	   in	   any	   of	   the	  healthcare	   facilities.	  This	  clearly	  reflects	  on	  the	  poor	   implementation	  of	  standard	  treatment	   guidelines	   for	   malaria	   in	   the	   country.	   However,	   adherence	   of	  prescribers	   with	   the	   standard	   treatment	   guidelines	   was	   significantly	   improved	  after	  receiving	  training	  on	  them	  in	  Nigeria	  (16).	  
5.	  CONCLUSION	  The	   present	   study	   revealed	   that	   despite	   the	   availability	   of	   standard	  treatment	   guidelines	   in	   the	   country,	   the	   pattern	   of	   prescription	   in	   terms	   of	  adherence	  and	  rationality	  remains	  poor.	  	  There	   is	   an	   urgent	   need	   to	   implement	   standard	   treatment	   guidelines	   and	  develop	  ways	  and	  means	  to	  ensure	  their	  availability	  and	  adherence	  of	  prescribers	  to	   them	   in	   the	   healthcare	   facilities.	   Malaria	   control	   program	   must	   play	   its	   role	  more	  effectively	  and	  should	  arrange	  special	  training	  programs	  for	  the	  prescribers	  on	  standard	  treatment	  guidelines.	  	  Regular	  continuing	  medical	  education	  (CME)	  must	  be	  made	  mandatory	  for	  the	  prescribers	  to	  attend,	  so	  as	  to	  update	  their	  knowledge.	  A	  check	  on	  the	  influence	  of	  pharmaceutical	  companies	  and	  their	  representatives	  needs	  to	  be	  maintained	  in	  health	  institutions,	  to	  minimize	  their	  influence	  on	  the	  drug	  prescription.	  All	  these	  measures	   would	   go	   a	   long	   way	   in	   provision	   of	   more	   rational,	   economical,	   and	  effective	  treatment	  to	  the	  patients	  and	  control	  of	  the	  disease.	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